BR0316395A - Vacina atenuada viva contra pleuropneumonia porcina - Google Patents

Vacina atenuada viva contra pleuropneumonia porcina

Info

Publication number
BR0316395A
BR0316395A BR0316395-4A BR0316395A BR0316395A BR 0316395 A BR0316395 A BR 0316395A BR 0316395 A BR0316395 A BR 0316395A BR 0316395 A BR0316395 A BR 0316395A
Authority
BR
Brazil
Prior art keywords
live attenuated
vaccine against
attenuated vaccine
against porcine
porcine pleuropneumonia
Prior art date
Application number
BR0316395-4A
Other languages
English (en)
Other versions
BRPI0316395B1 (pt
Inventor
Jaume Piñol Ribas
Sergi Bru Virgili
Enric Espuña Maso
Enrique Querol Murillo
Original Assignee
Hipra Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hipra Lab Sa filed Critical Hipra Lab Sa
Publication of BR0316395A publication Critical patent/BR0316395A/pt
Publication of BRPI0316395B1 publication Critical patent/BRPI0316395B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"VACINA ATENUADA VIVA CONTRA PLEUROPNEUMONIA PORCINA". A presente invenção fornece um método para obter uma cepa de Actinobacillus pleuropneumoniae, imunogênica e não hemolítica, que está modificada pelo menos em um segmento do gene apxIA e, opcionalmente, em um segmento do gene apxIIA, que codifica um domínio de transmembrana das exotoxinas Apx hemolíticas e citolíticas. Ela compreende também as cepas e a vacina viva atenuada contra pleuropneumonia porcina obtida com elas.
BRPI0316395A 2002-11-20 2003-11-17 vacina atenuada viva contra pleuropneumonia porcina BRPI0316395B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200202663A ES2233145B1 (es) 2002-11-20 2002-11-20 Vacuna viva atenuada contra la pleuroneumonia porcina.
PCT/EP2003/012839 WO2004045639A1 (en) 2002-11-20 2003-11-17 Live attenuated vaccine against porcine pleuropneumonia

Publications (2)

Publication Number Publication Date
BR0316395A true BR0316395A (pt) 2005-09-27
BRPI0316395B1 BRPI0316395B1 (pt) 2016-07-05

Family

ID=32319811

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0316395A BRPI0316395B1 (pt) 2002-11-20 2003-11-17 vacina atenuada viva contra pleuropneumonia porcina

Country Status (17)

Country Link
US (1) US7722882B2 (pt)
EP (1) EP1575610B1 (pt)
JP (1) JP2006510612A (pt)
KR (1) KR101164045B1 (pt)
CN (1) CN100435845C (pt)
AT (1) ATE543511T1 (pt)
AU (1) AU2003288088A1 (pt)
BR (1) BRPI0316395B1 (pt)
CA (1) CA2505869C (pt)
DK (1) DK1575610T3 (pt)
ES (2) ES2233145B1 (pt)
MX (1) MXPA05005387A (pt)
PL (1) PL212312B1 (pt)
PT (1) PT1575610E (pt)
RU (1) RU2351360C2 (pt)
TW (1) TW200504209A (pt)
WO (1) WO2004045639A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100460503C (zh) * 2007-01-26 2009-02-11 华中农业大学 一种不含抗性标记的猪胸膜肺炎放线杆菌血清1型双基因缺失突变株的疫苗及应用
CN101265457B (zh) * 2007-07-20 2011-01-26 华中农业大学 区分疫苗免疫和野毒感染动物的猪胸膜肺炎放线杆菌血清7型双基因缺失突变株的疫苗及应用
TWI392737B (zh) * 2008-11-27 2013-04-11 Intervet Int Bv 產製ＲＴＸ毒素ＡｐｘＩ或ＡｐｘIII 之方法
TWI461529B (zh) * 2008-11-27 2014-11-21 Intervet Int Bv 產製ＲＴＸ毒素ＡｐｘＩ之方法
CN102058880B (zh) * 2010-10-13 2012-11-21 青岛易邦生物工程有限公司 猪传染性胸膜肺炎三价灭活疫苗的生产方法
ES2416154B1 (es) 2011-11-09 2015-04-01 Laboratorios Hipra, S.A. Cepa viva atenuada de Actinobacillus pleuropneumoniae
CN102517232B (zh) * 2011-12-15 2013-07-31 中国农业科学院哈尔滨兽医研究所 一种不含抗性标记的猪胸膜肺炎放线杆菌双基因缺失株、其构建方法及应用
CN102796679B (zh) * 2012-01-16 2014-09-24 四川农业大学 血清5型猪胸膜肺炎放线杆菌Apx I C/Apx II C双基因缺失疫苗候选株
KR101491795B1 (ko) * 2013-06-13 2015-02-16 대한민국 신규한 액티노바실러스 플로르뉴모니아 혈청형 1번 균주, 이를 포함하는 진단용 조성물 및 백신 조성물
KR101491793B1 (ko) 2013-09-10 2015-02-16 대한민국 신규한 액티노바실러스 플로르뉴모니아 혈청형 12번 균주, 이를 포함하는 진단용 조성물 및 백신 조성물
KR101705098B1 (ko) * 2014-05-29 2017-02-10 전북대학교산학협력단 약독화된 살모넬라 변이주를 포함하는 돼지 흉막폐렴의 예방 또는 치료용 백신 조성물
CN105664148B (zh) * 2016-01-25 2019-05-07 华南农业大学 一种基因工程亚单位混合疫苗及其制备方法和应用
KR102018707B1 (ko) * 2017-07-31 2019-09-06 주식회사 고려비엔피 돼지 흉막폐렴의 예방 또는 치료용 백신 조성물
EP3689373A1 (en) 2019-01-30 2020-08-05 IDT Biologika GmbH Inactivated apxia, apxiia and apxiiia toxins
GB202011902D0 (en) 2020-07-30 2020-09-16 Imperial College Innovations Ltd Antinobacillus pleuropneumoniae vaccines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2170839A1 (en) * 1995-03-01 1996-09-02 Janet Macinnes Bacterial preparations, method for producing same, and their use as vaccines
AUPN631495A0 (en) * 1995-11-02 1995-11-23 Commonwealth Scientific And Industrial Research Organisation Vaccine and biological vector(I)

Also Published As

Publication number Publication date
ES2233145A1 (es) 2005-06-01
KR20050062662A (ko) 2005-06-23
BRPI0316395B1 (pt) 2016-07-05
RU2005118761A (ru) 2006-02-27
ES2381973T3 (es) 2012-06-04
CN1713921A (zh) 2005-12-28
AU2003288088A1 (en) 2004-06-15
MXPA05005387A (es) 2005-11-23
ATE543511T1 (de) 2012-02-15
PL376527A1 (pl) 2006-01-09
EP1575610A1 (en) 2005-09-21
JP2006510612A (ja) 2006-03-30
WO2004045639A1 (en) 2004-06-03
DK1575610T3 (da) 2012-05-14
CA2505869C (en) 2012-03-20
US7722882B2 (en) 2010-05-25
PL212312B1 (pl) 2012-09-28
PT1575610E (pt) 2012-03-16
ES2233145B1 (es) 2006-07-16
EP1575610B1 (en) 2012-02-01
CA2505869A1 (en) 2004-06-03
KR101164045B1 (ko) 2012-07-18
WO2004045639A8 (en) 2005-06-09
US20060051371A1 (en) 2006-03-09
RU2351360C2 (ru) 2009-04-10
TW200504209A (en) 2005-02-01
CN100435845C (zh) 2008-11-26

Similar Documents

Publication Publication Date Title
BR0316395A (pt) Vacina atenuada viva contra pleuropneumonia porcina
CY1115842T1 (el) Συμπληρωμενο ομv εμβολιο κατα μηνιγγιtiδοκοκκου
DK1263936T3 (da) andret stamme af den modificerede Vacciniavirus Ankara (MVA)
FR10C0044I1 (fr) Solubilisation de polysaccharides capsulaires
MXPA04001982A (es) Factor ix modificado.
ATE426412T1 (de) Adjuvante influenza-vakzine
TNSN07387A1 (en) C.perfringens alpha toxoid vaccine
CY1107390T1 (el) Εμβολιο εναντι αντιγονων απο βακτηριδια
BR0112928A (pt) Vacinas para proteção de amplo espectro contra doenças causadas por neisseria meningitidis
MX2021014948A (es) Metodos de tratamiento de pacientes con una composicion inmunogenica que protege contra el seroripo 29 de s. pneumoniae.
UA98506C2 (en) Attenuated mycoplasma gallisepticum strains
TW200731986A (en) Use of vaccines for the treatment/prevention of the transmission of pathogens
DE60226175D1 (de) Mycobakterieller impfstoff
MX2010003719A (es) Vacuna de mycoplasma bovis y metodos de uso de la misma.
MY152546A (en) A non-reusable circumcision clamp
NZ591188A (en) West nile virus vaccine
MX2012004133A (es) Composiciones que comprenden adyuvante, macrolido y antigeno proteico y procedimientos de uso de las mismas.
DK2007419T3 (da) Vaccine mod mycoplasma PRRSV
SG147465A1 (en) Vaccine
BR112022009507A2 (pt) Uma nova vacina contra heamophilus parasuis
MY158116A (en) Combination vaccine against streptococcus
BRPI0417880A (pt) vacina de combinação para a proteção de aves domésticas contra ornithobacterium rhinotracheale, uso de uma cepa de ornithobacterium rhinotracheale superatenuada viva e um vìrus de aves domésticas atenuado, método para a preparação de uma vacina de combinação, e, kit de vacinação
WO2023092100A3 (en) Methods of administering chimeric vaccines
MX2022004967A (es) Composiciones para el cuidado personal de ph bajo estables y metodos para las mismas.
BR112022023261A2 (pt) Imunização bacteriana usando vacina de nanopartícula

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/07/2016, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 13A ANUIDADE.

B21H Decision of lapse of a patent or of a certificate of addition of invention cancelled [chapter 21.8 patent gazette]
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: REFERENTE AO DESPACHO 21.6 PUBLICADO NA RPI 2579 DE 2020-06-09